Brief: Idera Pharmaceuticals Reports Second Quarter Financial Results

Aceragen

04/08/2020 22:25

Aug 4 (Reuters) - Idera Pharmaceuticals Inc  IDRA.O :
    * IDERA PHARMACEUTICALS REPORTS SECOND QUARTER FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
    * Q2 LOSS PER SHARE $0.72
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.40 -- REFINITIV IBES
DATA
    * ORR AND OTHER PRELIMINARY DATA EXPECTED IN Q1 OF 2021 FOR
ILLUMINATE-301
    * IDERA PHARMACEUTICALS - ANTICIPATE THAT CURRENT CASH, CASH
EQUIVALENTS, AND SHORT-TERM INVESTMENTS WILL FUND OPERATIONS
INTO Q2 OF 2021

Source text for Eikon:  ID:nGNX5rjMl6 
Further company coverage:  IDRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))